Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients
β Scribed by Chung-Feng Huang; Chia-Yen Dai; Jee-Fu Huang; Wan-Long Chuang; Ming-Lung Yu
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 369 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no
Polymorphisms near the IL28B gene, which code for interferon (IFN)-Ξ»3, predict response to pegylated interferon-Ξ± (PEG-IFN) and ribavirin treatment in hepatitis C virus (HCV) genotype 1 infected patients. Follow-up studies of the effect of IL28B gene in HCV non-genotype 1 infected patients have almo
Polymorphism in the interleukin-28B (IL28B) gene region, encoding interferon (IFN)-k3, is strongly predictive of response to antiviral treatment in the nontransplant setting. We sought to determine the prevalence and impact on clinical outcomes of donor and recipient IL28B genotypes among liver tran
## Abstract It has been reported that genetic polymorphisms near the __IL28B__ gene or amino acid substitutions in hepatitis C virus (HCV) core protein are associated with the clinical outcome of peginterferon (PEGβIFN) and ribavirin combination therapy. The impact of these factors on the pure sens
The vertical transmission of hepatitis C virus (HCV-VT) is a major route of HCV infection in children, but the risk factors remain incompletely understood. This study analyzed the role of interleukin 28B (IL28B) in HCV-VT and in the spontaneous clearance of HCV among infected infants. Between 1991 a